Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-950
Closed -$265K 185
2025
Q2
$265K Buy
+950
New +$269K 0.13% 59
2025
Q1
Sell
-159
Closed -$41K 177
2024
Q4
$41K Hold
159
0.02% 125
2024
Q3
$51K Sell
159
-5
-3% -$1.64K 0.02% 126
2024
Q2
$51K Sell
164
-33
-17% -$9.7K 0.02% 125
2024
Q1
$56K Sell
197
-9
-4% -$2.63K 0.03% 134
2023
Q4
$59K Hold
206
0.03% 127
2023
Q3
$55K Sell
206
-387
-65% -$96.6K 0.04% 121
2023
Q2
$132K Sell
593
-29
-5% -$6.73K 0.08% 56
2023
Q1
$150K Sell
622
-78
-11% -$19.1K 0.1% 43
2022
Q4
$184K Buy
+700
New +$188K 0.1% 57
2020
Q3
$646K Buy
2,541
+142
+6% +$35.2K 0.92% 24
2020
Q2
$566K Sell
2,399
-464
-16% -$106K 0.61% 25
2020
Q1
$580K Sell
2,863
-1,009
-26% -$220K 0.9% 25
2019
Q4
$933K Buy
+3,872
New +$854K 0.88% 26

Other funds holding AMGN

Horizon Bancorp's AMGN Position: Q3 2025 in Review

Horizon Bancorp sold out of Amgen (AMGN) in Q3 2025, closing a stake of 950 shares — an estimated $265K sold.

Horizon Bancorp first reported a position in AMGN in Q4 2019 and held it in 14 quarters. The position peaked at $933K in Q4 2019. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Horizon Bancorp reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Horizon Bancorp sold 950 Amgen shares in Q3 2025, an estimated $265K.
  • Horizon Bancorp first reported a position in Amgen in Q4 2019 and held it in 14 quarters.
  • Horizon Bancorp's Amgen position peaked at $933K in Q4 2019.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Horizon Bancorp's 13F filing for Q3 2025, filed 29 Oct 2025.